This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Oct 1;6(10):1634-1635.

doi: 10.1001/jamaoncol.2020.2722.

Assessing Expression of PD-L1 in Tumor-Associated Macrophages-Reply

Salma Jabbour¹, Charles B Simone 2nd², Jyoti Malhotra¹

Affiliations

Affiliations

¹ Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick.
² Department of Radiation Oncology, New York Proton Center, New York, New York.

PMID: 32761104
DOI: 10.1001/jamaoncol.2020.2722

Comment

Assessing Expression of PD-L1 in Tumor-Associated Macrophages-Reply

Salma Jabbour et al. JAMA Oncol. 2020.

. 2020 Oct 1;6(10):1634-1635.

doi: 10.1001/jamaoncol.2020.2722.

Authors

Salma Jabbour¹, Charles B Simone 2nd², Jyoti Malhotra¹

Affiliations

¹ Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick.
² Department of Radiation Oncology, New York Proton Center, New York, New York.

PMID: 32761104
DOI: 10.1001/jamaoncol.2020.2722

No abstract available

PubMed Disclaimer

Comment on

Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial.
Jabbour SK, Berman AT, Decker RH, Lin Y, Feigenberg SJ, Gettinger SN, Aggarwal C, Langer CJ, Simone CB 2nd, Bradley JD, Aisner J, Malhotra J. Jabbour SK, et al. JAMA Oncol. 2020 Jun 1;6(6):848-855. doi: 10.1001/jamaoncol.2019.6731. JAMA Oncol. 2020. PMID: 32077891 Free PMC article. Clinical Trial.
Assessing Expression of PD-L1 in Tumor-Associated Macrophages.
Zhang J, Fu J, Zhang G. Zhang J, et al. JAMA Oncol. 2020 Oct 1;6(10):1634. doi: 10.1001/jamaoncol.2020.2698. JAMA Oncol. 2020. PMID: 32761136 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program